Study Details
Full Title
A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (allo-HCT)
Principal Investigator
Kris
Mahadeo
Protocol Number
PRO00119684
NCT ID
NCT07387367
Phase
III
Enrollment Status
Open to Enrollment